HC Wainwright Cuts Price For This Small Cap ‘Reflecting Potential Pause In Hemophilia Program’
Earlier this month, Freeline Therapeutics Holdings PLC (NASDAQ: FRLN) reported 2Q22 earnings focusing on the pipeline’s progress. Notably, the company said it…